KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

BeOne Medicines (ONC) Return on Sales: 2015-2025

Historic Return on Sales for BeOne Medicines (ONC) over the last 9 years, with Sep 2025 value amounting to 0.01%.

  • BeOne Medicines' Return on Sales rose 27.00% to 0.01% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.01%, marking a year-over-year increase of 27.00%. This contributed to the annual value of -0.17% for FY2024, which is 19.00% up from last year.
  • As of Q3 2025, BeOne Medicines' Return on Sales stood at 0.01%, which was up 135.40% from -0.04% recorded in Q2 2025.
  • BeOne Medicines' Return on Sales' 5-year high stood at 0.01% during Q3 2025, with a 5-year trough of -2.22% in Q1 2022.
  • Moreover, its 3-year median value for Return on Sales was -0.26% (2024), whereas its average is -0.36%.
  • In the last 5 years, BeOne Medicines' Return on Sales soared by 480bps in 2021 and then crashed by 83bps in 2022.
  • Quarterly analysis of 5 years shows BeOne Medicines' Return on Sales stood at -1.23% in 2021, then declined by 19bps to -1.42% in 2022, then spiked by 106bps to -0.36% in 2023, then increased by 19bps to -0.17% in 2024, then increased by 27bps to 0.01% in 2025.
  • Its last three reported values are 0.01% in Q3 2025, -0.04% for Q2 2025, and -0.09% during Q1 2025.